Compare TTRX & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTRX | CTM |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 93.7M |
| IPO Year | N/A | 2022 |
| Metric | TTRX | CTM |
|---|---|---|
| Price | $3.42 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $3.00 |
| AVG Volume (30 Days) | 17.3K | ★ 895.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.63 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $44,764,852.00 |
| Revenue This Year | N/A | $23.00 |
| Revenue Next Year | N/A | $11.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.57 | $0.79 |
| 52 Week High | $5.98 | $1.56 |
| Indicator | TTRX | CTM |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 54.55 |
| Support Level | $2.64 | $0.95 |
| Resistance Level | $5.12 | $1.13 |
| Average True Range (ATR) | 0.23 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 29.58 | 84.44 |
Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.